Evidence map›Paper›PMID 32661204›Full record

ArticleJournal of genetics2020

Promoter polymorphisms of the

Eliakym Arámbula-Meraz, Martín Irigoyen-Arredondo, Dora Cedano-Prieto, Enrique Romo-Martínez, Fred Luque-Ortega, Verónica Picos-Cárdenas, Marco Alvarez-Arrazola, Noemí García-Magallanes

Abstract read
PubMed
In one paragraph

Article in Journal of genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Eliakym Arámbula-MerazFacultad de Ciencias Químico Biológicas, Laboratorio de Genética y Biología Molecular, Universidad Autónoma de Sinaloa, Av. de las Américas y Universitarios s/n Ciudad Universitaria, C.P. 80010 Culiacán, Sinaloa, Mexico. ngmagallanes26@gmail.com.
Martín Irigoyen-Arredondo
Dora Cedano-Prieto
Enrique Romo-Martínez
Fred Luque-Ortega
Verónica Picos-Cárdenas
Marco Alvarez-Arrazola
Noemí García-Magallanes
Autonomous University of Sinaloa · MXUniversidad Politécnica de SinaloaMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In male, the prostate cancer (PCa) is one of the most frequent neoplasias and the second cause of cancer deaths worldwide. In 2015, more than 6000 men died in Mexico due to this disease. In this regard, prostate cancer associated gene 3 (

Indexed as

Polymorphism, GeneticPromoter Regions, GeneticAgedAntigens, NeoplasmBiomarkers, TumorFollow-Up StudiesGenotypeHumansMalePrognosisProstatic HyperplasiaProstatic NeoplasmsAntigens, NeoplasmBiomarkers, Tumorprostate cancer antigen 3, human

Identifiers

PMID32661204
OpenAlexW3033908862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.